Print

Zeltia Group (18494051.MA) Says Yondelis on Track, Delays Neuropharma Unit IPO  
3/6/2008 8:36:40 AM

MADRID, March 6 (Reuters) - Spanish pharmaceuticals firm Zeltia said on Thursday anti-cancer drug Yondelis was meeting forecasts but said the listing of its Neuropharma unit would be delayed because of poor markets.
//-->